TSHA
Taysha Gene Therapies Inc.
$2.90
+$0.02(+0.87%)
80
Overall
--
Value
80
Tech
--
Quality
Market Cap
$774.74M
Volume
1.15M
52W Range
$1.05 - $3.40
Target Price
$8.67
Key Metrics Overview
| Market Cap | $774.74M | P/E Ratio | N/A |
| 52W High | $3.40 | 52W Low | $1.05 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 57.4% | 52W Position | 78.5% |
| Overall Score | 80 | Value Score | -- |
| Quality Score | -- | Technical Score | 80 |
Growth Analysis
| EPS Current Est | $-0.36 | EPS Next Est | $-0.4 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TSHA | $2.90 | +0.9% | 1.15M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Taysha Gene Therapies Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW